Table 1.
Characteristic | All (nā=ā31) |
---|---|
Age | |
Median (range) | 60 (22ā83) |
Sex | |
Male (%) | 17 (55) |
Female (%) | 14 (45) |
Diagnosis | |
Glioblastoma, IDH-wildtype, WHO grade IV* | 16 |
Glioblastoma, IDH mutant, WHO grade IV | 2 |
Anaplastic astrocytoma, IDH mutant, WHO grade III | 3 |
Anaplastic Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, WHO grade III | 4 |
Diffuse astrocytoma, IDH mutant, WHO grade II | 0 |
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, WHO grade II | 6 |
*Two patients had IDH-wildtype astrocytomas with histologic grade of III; however, these were considered molecular glioblastoma using the cIMPACT-NOW criteria and included in the study as such12.